Taiwan Advance Bio-Pharmaceutical (ROCO:4186) OCF Margin %: 26.89% (As of Dec. 2025)


ROCO:4186 Taiwan Advance Bio-Pharmaceutical Inc ROCO:4186
52 GF Score
Price NT$10.25
GF Value NT$17.86
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Taiwan Advance Bio-Pharmaceutical OCF Margin %?

Taiwan Advance Bio-Pharmaceutical ROCO:4186 +0.99% 52 OCF Margin % is 26.89% as of Dec. 2025. GuruFocus rates ROCO:4186 with a GF Score™ of 52/100 and a GF Value™ of NT$17.86 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 960 Biotechnology companies, Taiwan Advance Bio-Pharmaceutical ranks better than 79.27% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Taiwan Advance Bio-Pharmaceutical's Cash Flow from Operations for the six months ended in Dec. 2025 was NT$52.6 Mil. Taiwan Advance Bio-Pharmaceutical's Revenue for the six months ended in Dec. 2025 was NT$195.4 Mil. Therefore, Taiwan Advance Bio-Pharmaceutical's OCF Margin % for the quarter that ended in Dec. 2025 was 26.89%.

As of today, Taiwan Advance Bio-Pharmaceutical's current OCF Yield % is 5.99%.

The historical rank and industry rank for Taiwan Advance Bio-Pharmaceutical's OCF Margin % or its related term are showing as below:

ROCO:4186' s OCF Margin % Range Over the Past 10 Years
Min: -93.13   Med: -20.56   Max: 14.56
Current: 14.56


During the past 13 years, the highest OCF Margin % of Taiwan Advance Bio-Pharmaceutical was 14.56%. The lowest was -93.13%. And the median was -20.56%.

ROCO:4186's OCF Margin % is ranked better than
79.27% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs ROCO:4186: 14.56


Taiwan Advance Bio-Pharmaceutical OCF Margin % Related Terms


Taiwan Advance Bio-Pharmaceutical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Taiwan Advance Bio-Pharmaceutical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Advance Bio-Pharmaceutical OCF Margin % Chart

Taiwan Advance Bio-Pharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.76 -6.47 3.99 2.35 14.56

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.39 -2.35 5.87 0.34 26.89

ROCO:4186 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Taiwan Advance Bio-Pharmaceutical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Advance Bio-Pharmaceutical OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Advance Bio-Pharmaceutical's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Taiwan Advance Bio-Pharmaceutical's OCF Margin % falls into.


ROCO:4186
52GF Score
Taiwan Advance Bio-Pharmaceutical Inc ROCO:4186
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiwan Advance Bio-Pharmaceutical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Taiwan Advance Bio-Pharmaceutical's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=53.13/364.79
=14.56 %

Taiwan Advance Bio-Pharmaceutical's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=52.556/195.441
=26.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 26.89% mean?
Taiwan Advance Bio-Pharmaceutical (ROCO:4186) has a OCF Margin % of 26.89% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Taiwan Advance Bio-Pharmaceutical and its competitors. According to the industry distribution chart, Taiwan Advance Bio-Pharmaceutical ranks #199 out of 960 companies in the Biotechnology industry, placing it in the top 20.7%.
Is Taiwan Advance Bio-Pharmaceutical's OCF Margin % too high?
Taiwan Advance Bio-Pharmaceutical's current OCF Margin % is 26.89%. Based on the distribution chart, Taiwan Advance Bio-Pharmaceutical ranks #199 out of 960 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Taiwan Advance Bio-Pharmaceutical has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Taiwan Advance Bio-Pharmaceutical's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Taiwan Advance Bio-Pharmaceutical ranks #199 out of 960 companies for OCF Margin %. This places Taiwan Advance Bio-Pharmaceutical in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Taiwan Advance Bio-Pharmaceutical and its competitors. Taiwan Advance Bio-Pharmaceutical's current OCF Margin % is 26.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiwan Advance Bio-Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Taiwan Advance Bio-Pharmaceutical (ROCO:4186) is currently considered Possible Value Trap. The stock's GF Value™ is NT$17.86, compared to a current price of NT$10.25 — trading 42.6% below its estimated fair value. The current OCF Margin % is 26.89%. Taiwan Advance Bio-Pharmaceutical's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Taiwan Advance Bio-Pharmaceutical (ROCO:4186), the current OCF Margin % is 26.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Overvalued in 2026?

Based on GuruFocus' analysis, Taiwan Advance Bio-Pharmaceutical stock appears to be undervalued. The current stock price of NT$10.25 is trading 42.6% below its estimated GF Value™ of NT$17.86. GuruFocus considers Taiwan Advance Bio-Pharmaceutical to be Possible Value Trap.

Key valuation signals for ROCO:4186:

  • OCF Margin %: 26.89%
  • GF Value™: NT$17.86 vs. price of NT$10.25 (42.6% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4186 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Taiwan Advance Bio-Pharmaceutical Business Description

Address No. 363, Section 2, Fuxing South Road, 5th Floor, Daan District, New Taipei City, TWN, 22180
Taiwan Advance Bio-Pharmaceutical Inc operates in the food safety industry. The company's products include a Food safety test kit, Animal test kit, Pesticide test kit, Mycotoxin test kit, Nuleic acid extraction kit.
52GF Score

Get the complete analysis for ROCO:4186

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.25
Price
NT$17.86
GF Value